Richard Cavanagh - BlackRock Science Independent Co-Chairman of the Board of Trustees
BST Etf | USD 34.43 0.33 0.97% |
Mr. Richard E. Cavanagh is Independent Chairman of the Board of Blackrock Science And Technology Trust . Mr. Cavanagh brings to the Board a wealth of practical business knowledge and leadership as an experienced directortrustee of various public and private companies. In particular, because Mr. Cavanagh served for over a decade as President and Chief Executive Officer of The Conference Board, Inc., a global business research organization, he is able to provide the Board with expertise about business and economic trends and governance practices. Mr. Cavanagh created the blue ribbon Commission on Public Trust and Private Enterprise in 2002, which recommended corporate governance enhancements. Mr. Cavanaghs service as a director of The Guardian Life Insurance Company of America and as a senior advisor and director of The Fremont Group provides added insight into investment trends and conditions. Mr. Cavanaghs longstanding service on the boards of the ClosedEnd Complex also provides him with a specific understanding of the Trust, its operations, and the business and regulatory issues facing the Trust. Mr. Cavanaghs independence from the Trust and the Advisor enhances his service as Chair of the Board, Chair of the Leverage Committee, Chair of the Executive Committee and as a member of the Governance and Nominating Committee, Compliance Committee and Performance Oversight Committee.
Age | 75 |
Tenure | 7 years |
Phone | 212 810 5300 |
Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Richard Cavanagh Latest Insider Activity
Tracking and analyzing the buying and selling activities of Richard Cavanagh against BlackRock Science etf is an integral part of due diligence when investing in BlackRock Science. Richard Cavanagh insider activity provides valuable insight into whether BlackRock Science is net buyers or sellers over its current business cycle. Note, BlackRock Science insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Science'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Richard Cavanagh over a month ago Acquisition by Richard Cavanagh of 115 shares of BlackRock MIT at 14.3767 subject to Rule 16b-3 | ||
Richard Cavanagh over three months ago Acquisition by Richard Cavanagh of 100 shares of BlackRock Virginia at 20.1 subject to Rule 16b-3 | ||
Richard Cavanagh over six months ago Acquisition by Richard Cavanagh of 500 shares of Blackrock Municipal at 22.64 subject to Rule 16b-3 | ||
Richard Cavanagh over six months ago Acquisition by Richard Cavanagh of 100 shares of BlackRock Virginia at 20.1 subject to Rule 16b-3 |
Similar Fund Executives
Found 14 records | One Year Return | ||
Oleg Pohotsky | Tekla Healthcare Investors | 73 | |
William Park | Eaton Vance Enhanced | 74 | |
Catherine Paglia | Columbia Seligman Premium | 68 | |
Hans Kertess | Pimco Corporate Income | 82 | |
Deborah DeCotis | Pimco Corporate Income | 69 | |
Robert Steers | Cohen Steers Total | 67 | |
Robert Steers | Cohen Steers Qualityome | 67 | |
Joseph Harvey | Cohen Steers Total | 57 | |
Robert Steers | Cohen Steers Reit | 67 | |
Karen Robards | BlackRock Health Sciences | 71 | |
Robert Steers | Cohen And Steers | 67 | |
Jeremy May | Reaves Utility If | 49 | |
Jeremy Deems | Reaves Utility If | 43 | |
Joseph Harvey | Cohen Steers Reit | 57 |
BlackRock Science Tech Money Managers
Henry Gabbay, Independent Trustee | ||
Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
Frank Fabozzi, Independent Trustee | ||
J Holloman, Independent Trustee | ||
Janey Ahn, Secretary | ||
John Perlowski, President, Chief Executive Officer, Trustee | ||
Michael Castellano, Independent Trustee | ||
Cynthia Egan, Independent Trustee | ||
Jay Fife, Treasurer | ||
R Hubbard, Independent Trustee | ||
Jonathan Diorio, Vice President | ||
Robert Fairbairn, Trustee | ||
Neal Andrews, Chief Financial Officer | ||
Trent Walker, Chief Financial Officer | ||
Catherine Lynch, Independent Trustee | ||
Stayce Harris, Independent Trustee | ||
W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Shares Outstanding | 33.68 M | |||
Shares Owned By Insiders | 0.01 % | |||
Shares Owned By Institutions | 18.53 % | |||
Number Of Shares Shorted | 14.74 K | |||
Price To Earning | 5.78 X | |||
Short Ratio | 0.09 X | |||
Earnings Per Share | 5.41 X | |||
Number Of Employees | 17 | |||
Market Capitalization | 1 B | |||
Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.